2007 Public Health Advisories

Fentanyl Transdermal System (Patch) (marketed as Duragesic and generics) (12/21/2007)

Erythropoiesis-Stimulating Agents (ESAs): Epoetin alfa (marketed as Procrit and Epogen), Darbepoetin alfa (marketed as Aranesp) (11/8/2007)

Fentanyl Buccal Tablets (marketed as Fentora) (9/26/2007)

Use of Codeine By Some Breastfeeding Mothers May Lead To Life-Threatening Side Effects In Nursing Babies (8/17/2007)

Nonprescription Cough and Cold Medicine Use in Children (8/15/2007)

Colistimethate (marketed as Coly-Mycin M and generic products) (6/28/2007)

Tegaserod maleate (marketed as Zelnorm) (3/30/2007)

Pergolide (marketed as Permax) (3/29/2007)

Interferon gamma-1b (marketed as Actimmune) (3/9/2007)

Erythropoiesis-Stimulating Agents (ESAs): Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) (3/9/2007)

Life-Threatening Side Effects with the Use of Skin Products Containing Numbing Ingredients for Cosmetic Procedures (2/6/2007)